Top

Published in:

01-08-2012 | Original Article

Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma

Authors: Gokulan Ravindran, Halagowder Devaraj

Published in: Clinical Oral Investigations | Issue 4/2012

Abstract

The present study focuses on the correlation between the expression pattern of β-catenin (component of Wnt signaling), ΔNp63 (proliferation marker), and Notch 1 (transmembrane receptor) in oral squamous cell carcinoma. The study also aims to investigate the interaction between β-catenin and ΔNp63 in oral cancer. Furthermore, we also analyzed the prognostic significance of β-catenin, ΔNp63, and Notch 1 in oral squamous cell carcinoma. Immunohistochemical analysis of β-catenin, ΔNp63, and Notch 1 were done in 62 cases of oral squamous cell carcinoma. Co-immunoprecipitation analysis was done to study the possible interaction between β-catenin and ΔNp63 in oral cancer. Kaplan–Meier method was used to estimate overall and disease-free survival, and the Log-rank test was used to compare the resulting curves. Statistically significant positive correlation was found between the localization of β-catenin and the expression of ΔNp63 (p = 0.001**, r _s = 0.427), whereas, no significant association was found between the expression pattern of β-catenin and Notch 1. Interestingly, interaction between β-catenin and ΔNp63 was observed in oral carcinoma. Moreover, β-catenin and ΔNp63 may be related to worst survival in oral carcinoma. Statistically significant positive association between localization of β-catenin and expression of ΔNp63 suggests that they might have dependent roles in maintaining the proliferation of oral carcinoma cells. In addition, the downregulated expression of Notch 1 was related to invasion and differentiation status of oral carcinoma cells. Furthermore, β-catenin and ΔNp63 may be used as independent prognostic markers of oral carcinoma. On the other hand, interaction of β-catenin with ΔNp63 may be a key event in maintaining the proliferation of oral carcinoma cells. The present study indicates that β-catenin and ΔNp63 may be used as independent prognostic markers of oral carcinoma and the interaction of β-catenin with ΔNp63 may be a crucial event in regulating proliferation and differentiation of oral carcinoma cells, which may be used as a target for therapeutic implications.

Available only for authorised users

Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef

Ishida K, Ito S, Wada N, Deguchi H, Hata T, Hosoda M, Nohno T (2007) Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer 6:62PubMedCrossRef

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512PubMedCrossRef

Barker N, Clevers H (2000) Catenins, Wnt signaling and cancer. Bioessays 22:961–965PubMedCrossRef

Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H (2000) Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 82:1689–1693PubMedCrossRef

Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H (2007) Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcino 46:807–817CrossRef

Behbod F, Rosen JM (2005) Will cancer stem cells provide new therapeutic targets? Carcinogenesis 26:703–711PubMedCrossRef

Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci 98:3156–3161PubMedCrossRef

Moll UM (2003) The role of p63 and p73 in tumour formation and progression: coming of age toward clinical usefulness. Clin Cancer Res 9:5437–5441PubMed

10.

Parsa R, Yang A, McKeon F, Green H (1999) Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 113:1099–1105PubMedCrossRef

11.

Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494–501PubMed

12.

Chen YK, Hsue SS, Lin LM (2005) Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 34:232–239PubMedCrossRef

13.

Nylander K, Coates PJ, Hall PA (2000) Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 87:368–372PubMedCrossRef

14.

Allenspach EJ, Maillard I, Aster JC, Pear WS (2002) Notch signaling in cancer. Cancer Biol Ther 1:466–476PubMedCrossRef

15.

Brennan K, Brown AM (2003) Is there a role for Notch signaling in human breast cancer? Breast Cancer Res 5:69–75PubMedCrossRef

16.

Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G, Koster MI, Zhang Z, Wang J, Tommasi di Vignano A, Kitajewski J, Chiorino G, Roop DR, Missero C, Dotto GP (2006) Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 20:1028–1042PubMedCrossRef

17.

Su L, Morgan PR, Lane EB (1996) Keratin 14 and 19 expression in normal, dysplastic and malignant oral epithelia. A study using in situ hybridization and immunohistochemistry. J Oral Pathol Med 25:293–301PubMedCrossRef

18.

Presland RB, Dale BA (2000) Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 11:383–408PubMedCrossRef

19.

Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H (2007) Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 18:639–643PubMed

20.

Byrne C, Tainsky M, Fuchs E (1994) Programming gene expression in developing epidermis. Development 120:2369–2383PubMed

21.

Pindborg JJ, Reichart PA, Smith CJ, der waal Van I (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Heidelberg, SpringerCrossRef

22.

Minter HA, Eveson JW, Huntley S, Elder DJE, Hague A (2003) The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin Cancer Res 9:1885PubMed

23.

Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J (2007) Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 67:501–510PubMedCrossRef

24.

Pinilla MR, Peralto JLR, Hitt R, Sanchez JJ, Verde LS, Alameda F, Ballestin C, Cespedes MS (2005) β-Catenin, Nf-kB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Lett 230:141–148CrossRef

25.

Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D (2001) p53 associates with and targets ΔNp63 into a protein degradation pathway. Proc National Acad Sci 98:1817–1822CrossRef

26.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed

27.

Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, Poliak N, Califano J, Trink B, Ratovitski E, Sidransky D (2002) ΔNp63 induces β-catenin nuclear accumulation and signaling. Cancer Cell 1:369–379PubMedCrossRef

28.

Tysnes BB, Bjerkvig R (2007) Cancer initiation and progression: involvement of stem cells and the microenvironment. Biochim Biophys Acta 1775:283–297PubMed

29.

Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111PubMedCrossRef

30.

Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3:565–577PubMedCrossRef

31.

Cai Z-G, Shi X-J, Gao Y, Wei M-J, Wang C-Y, Yu G-Y (2008) β-catenin expression pattern in primary oral squamous cell Carcinoma. Chin Med J 121:1866–1870PubMed

32.

Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F, Dotto GP (2001) Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427–3436PubMedCrossRef

33.

Proweller A, Tu L, Lepore JJ, Cheng L, Lu MM, Seykora J, Millar SE, Pear WS, Parmacek MS (2006) Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 66:7438–7444PubMedCrossRef

34.

Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N (2005) Abnormal β-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, ki-67 labeling index, and clinicopathological feature. Hum Pathol 36:234–241PubMedCrossRef

35.

Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S, Bufo P, Piattelli A (2005) P63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36:187–194PubMedCrossRef

36.

Moergel M, Abt E, Stockinger M, Kunkel M (2010) Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol 46:667–671PubMedCrossRef

Title: Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma
Authors: Gokulan Ravindran
Halagowder Devaraj
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Clinical Oral Investigations / Issue 4/2012
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-011-0605-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Increased systemic elastase and C-reactive protein in aggressive periodontitis (CLOI-D-00160R2)

Clinical evaluation on porcelain laminate veneers bonded with light-cured composite: results up to 7 years

Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts

Peri-implant bone changes following tooth extraction, immediate placement and loading of implants in the edentulous maxilla

Microleakage of silorane- and methacrylate-based class V composite restorations

Influence of gaseous ozone in peri-implantitis: bactericidal efficacy and cellular response. An in vitro study using titanium and zirconia